Piramal Enterprises to acquire Janssen's injectable anaesthesia products for $155 mn
Piramal Enterprises announced that its wholly owned Critical Care subsidiary in the UK has entered into an agreement to acquire five anesthesia and pain management injectable products from Janssen Pharmaceutica NV, in an all cash deal for an upfront consideration of US$155 million, and up to an additional US$20 million. The products to be acquired are five injectable versions of well-established Janssen brands, Sublimaze (fentanyl citrate), Sufenta (sufentanil citrate), Rapifen (alfentanil hydrochloride), Dipidolor (piritramide), and Hypnomidate (etomidate) (the “Products”). Read More
JLT Independent acquires Vantage Insurance Brokers
JLT Independent Insurance Brokers Pvt. Ltd. announced that it has acquired Vantage Insurance Brokers & Risk Advisor Pvt Ltd’s employee benefits insurance brokerage portfolio in India. Vantage operates one of India’s largest employee benefits insurance portfolios with services that include insurance broking, health risk advisory and benefits consulting. JLT Independent is the Specialty joint venture between Jardine Lloyd Thompson Group plc (JLT) and Sunidhi Group, a leading Indian financial services group with over 80 branches across India. Read More
Punjab Chemicals approves using overdue export proceeds to acquire shares in Argentina unit
The board of directors of the company in their meeting held on October 10, 2016, to utilize the overdue export proceeds of Euro 34,76,978 and USD Rs 87,500 valuing Rs 25,94,19,394/- as per the prevailing exchange rate at the time of post facto approval from the RBI, from SD Agchem (Europe) N.V, Belgium, a wholly owned subsidiary of the company, by capitalising the export proceeds by acquiring shares in the company's step down subsidiary viz. Sintesis Quimica SAIC, Argentina, in accordance with the approval received from Reserve Bank of India dated March 31, 2016. Read More
Polycom announces completion of acquisition by Affiliates of Siris Capital Group, LLC
Polycom, Inc., a global leader in helping organisations achieve new levels of teamwork, efficiency and productivity by unleashing the power of human collaboration, announced the completion of its acquisition by affiliates of Siris Capital Group, LLC (“Siris” or “Siris Capital”) in a transaction reflecting an equity value of approximately $2.0 billion in cash. Polycom’s stock will cease trading on the NASDAQ under the ticker symbol PLCM, effective. Read More
- Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
- Now Save Rs.3150 on your Demat Account ...Click here
- Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
- Get the most detailed result analysis on the web - Real Fast!
- Actionable & Award-Winning Research on 500 Listed Indian Companies.